These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7246736)

  • 1. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
    Foord SM; Peters JR; Dieguez C; Jasani B; Hall R; Scanlon MF
    Endocrinology; 1984 Jul; 115(1):407-15. PubMed ID: 6428863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
    Oomizu S; Boyadjieva N; Sarkar DK
    Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP; Stringer LC; Freeman ME
    Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
    Faure N; Cronin MJ; Martial JA; Weiner RI
    Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
    Demarest KT; Moore KE; Riegle GD
    Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that the dopaminergic prolactin-inhibiting factor mechanism regulates only the depletion-transformation phase and not the release phase of prolactin secretion during suckling in the rat.
    Grosvenor CE; Mena F; Whitworth NS
    Endocrinology; 1980 Feb; 106(2):481-5. PubMed ID: 7353523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium ions: their role and mechanism of action in the control of prolactin release.
    Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
    Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
    Foord SM; Peters JR; Dieguez C; Shewring G; Hall R; Scanlon MF
    Endocrinology; 1986 Apr; 118(4):1319-26. PubMed ID: 3004910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol acutely reduces LH and prolactin secretion: possible involvement by dopamine.
    Ching M; Lin YC
    Alcohol; 1994; 11(2):105-12. PubMed ID: 8204196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro.
    Golander A; Barrett J; Hurley T; Barry S; Handwerger S
    J Clin Endocrinol Metab; 1979 Nov; 49(5):787-9. PubMed ID: 114530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
    Lafond J; Ducharme JR; Collu R
    Mol Cell Endocrinol; 1986 Mar; 44(3):219-25. PubMed ID: 3007237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
    Dutt A; Juneja HS
    Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolactin on the luteinizing hormone response to gonadotropin- releasing hormone in primary pituitary cell cultures during the ovine annual reproductive cycle.
    Gregory SJ; Townsend J; McNeilly AS; Tortonese DJ
    Biol Reprod; 2004 May; 70(5):1299-305. PubMed ID: 14695904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preovulatory prolactin surge: an evaluation of the role of dopamine.
    Arbogast LA; Ben-Jonathan N
    Endocrinology; 1988 Dec; 123(6):2690-5. PubMed ID: 3264239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.